China Conditionally OKs Public Use of 2nd COVID-19 Vaccine
China has conditionally approved a second COVID-19 vaccine for public use.The National Medical Products Administration said in a statement Saturday that regulators approved the use of Sinovac Biotech Ltd.’s CoronaVac the day before.A vaccine developed by a Chinese institute affiliated with the state-owned China National Pharmaceutical Group (Sinopharm) was approved for public use two months ago.The Sinovac vaccine, which is being administered in at least five other countries, was given emergency approval last July for people at high risk for infection, such as health care workers and employees of state-owned …